Human pro®lins are multifunctional, single-domain proteins which directly link the actin micro®lament system to a variety of signalling pathways via two spatially distinct binding sites. Pro®lin binds to monomeric actin in a 1:1 complex, catalyzes the exchange of the actin-bound nucleotide and regulates actin ®lament barbed end assembly. Like SH3 domains, pro®lin has a surface-exposed aromatic patch which binds to proline-rich peptides. Various multidomain proteins including members of the Ena/VASP and formin families localize pro®lin:actin complexes through pro®lin:poly-L-proline interactions to particular cytoskeletal locations (e.g. focal adhesions, cleavage furrows). Humans express a basic (I) and an acidic (II) isoform of pro®lin which exhibit different af®-nities for peptides and proteins rich in proline residues. Here, we report the crystallization and X-ray structure determination of human pro®lin II to 2.2 A Ê . This structure reveals an aromatic extension of the previously de®ned poly-L-proline binding site for pro®lin I. In contrast to serine 29 of pro®lin I, tyrosine 29 in pro®lin II is capable of forming an additional stacking interaction and a hydrogen bond with poly-L-proline which may account for the increased af®nity of the second isoform for proline-rich peptides. Differential isoform speci®city for proline-rich proteins may be attributed to the differences in charged and hydrophobic residues in and proximal to the poly-L-proline binding site. The actin-binding face remains nearly identical with the exception of ®ve amino acid differences. These observations are important for the understanding of the functional and structural differences between these two classes of pro®lin isoforms.
Introduction
In eukaryotic cells there exists a complex web of signal transduction pathways which function to convey signals from cell surface receptors to the proper intracellular targets. The actin micro®la-ment system is one of the major targets of signalling cascades whose activation is essential for fundamental cellular processes including motility (Stossel, 1993) , endo-and exocytosis (Perrin et al., 1992) , cytokinesis (Sanger et al., 1989) and determination of cell shape (Small, 1988) . Pro®lin plays a central role by integrating multiple signalling pathways and directly affecting actin ®lament dynamics. Via pro®lin, actin is linked to the phosphoinositide cycle and to a host of pathways in which speci®c proline-rich proteins play a role.
Pro®lin is an essential protein (Verheyen & Cooley, 1994; Witke et al, 1993) which forms a 1:1 complex with monomeric actin. Pro®lin was ®rst isolated from spleen and was thought to function as a sequesterer of monomeric actin (Carlsson et al., 1977) ; however, subsequent biochemical studies have shown its role to be more complex. In the presence of capped F-actin barbed ends, pro®lin acts as a sequesterer and causes the depolymerization of actin ®laments (Pollard & Cooper, 1984; Pantaloni & Carlier, 1993) . In the absence of ®la-ment end cappers, pro®lin complexed to ATP-actin adds to the barbed ends of growing actin ®laments (Pollard & Cooper, 1984; Pring et al., 1992; Pantaloni & Carlier, 1993; Korenbaum et al., 1998) . Also, pro®lin catalyzes actin nucleotide exchange in vitro, thereby having the potential to increase the pool of ATP-actin necessary for barbed end assembly (Mockrin & Korn, 1980; Nishida, 1985; Goldschmidt-Clermont et al., 1991b) . In agreement with its role as a key regulator of actin dynamics, pro®lin localizes to regions in the cell undergoing active cytoskeletal remodelling in vivo (Buss et al., 1992; Edamatsu et al., 1992; Finkel et al., 1994; Suetsugu et al, 1998; Wills et al, 1999) .
Pro®lin binds to proline-rich stretches in a variety of proteins including members of the Ena/ VASP Gertler et al., 1996) and formin families (Manseau et al., 1996; Watanabe et al., 1997; Evangelista et al., 1997; Chang et al., 1997) , drebrin (Mammato et al., 1998) , gephyrin (Mammato et al., 1998) , N-WASP (Suetsugu et al., 1998) , WIP (Ramesh et al., 1997) , dynamin I (Witke et al., 1998) , and the p85 subunit of PI3-kinase (Singh et al., 1996) . Members of the Ena/VASP family localize to focal adhesions and can interact with ActA on the surface of Listeria monocytogenes, a bacterial pathogen which utilizes actin to move through the cytoplasm (Chakraborty et al., 1995; Gertler et al., 1996) . Cell polarization and cytokinesis require formin proteins and via their formin homology 1 domains associate with pro®lin (for a review, see Wasserman, 1998) . Disruption of the Drosophila formin gene, diaphanous, results in defects in cytokinesis (Castrillon & Wasserman, 1994) , and mutations in the human homologue of diaphanous, DFNA1, have been linked to an autosomal dominant hearing disorder (Lynch et al., 1997) . Recruitment of pro®lin:actin complexes by these proline-rich ligands increases the local concentrations of actin necessary for the execution of various actin-driven processes.
Another way pro®lin links the cytoskeleton to signal transduction pathways is via a direct interaction with phosphoinositides. Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) causes the dissociation of pro®lin:actin complexes in vitro which frees actin for rapid polymerization (Lassing & Lindberg, 1985) . In addition, the PIP 2 :pro®lin complex inhibits the hydrolysis of PIP 2 by phospholipase C-g1 into second messengers (Goldschmidt-Clermont et al., 1990) which can be overcome by phosphorylation of the phospholipase (Goldschmidt-Clermont et al., 1991a) . After several structural and mutagenic investigations (Raghunathan et al., 1992; Haarer et al., 1993; Fedorov et al., 1994a; Sohn et al., 1995) it still remains unclear if pro®lin has a distinct phosphoinositide binding site(s); yet, pro®lin binds phosphoinositides with varying af®nities (PtdIns (3,4)P 2 > PtdIns(3,4,5)P 3 > PtdIns(4,5)P 2 ), suggesting some speci®city of binding (Lu et al., 1996) .
Mammals express two isoforms of pro®lin which are 62 % identical in amino acid sequence. In 1993, human pro®lin II was cloned and shown to be expressed in different tissues than human pro®lin I, with pro®lin I apparently the more ubiquitously expressed of the two isoforms (Honore Â et al., 1993) . The relative af®nities of pro®lin I and II for actin are comparable (Gieselmann et al., 1995; Lambrechts et al., 1995) ; however, opposing ®nd-ings have been reported for the relative af®nities of the pro®lin isoforms for PIP 2 (Gieselmann et al., 1995; Lambrechts et al., 1997) . In contrast, differences between pro®lin I and II in their af®nities towards poly-L-proline rich peptides (Lambrechts et al., 1997; Jonckheere et al., 1999) and proteins (Witke et al., 1998; Suetsugu et al., 1998) have been clearly established. Studies with continuous stretches of proline as well as VASP-based proline peptides have shown pro®lin II to bind more tightly than pro®lin I (Lambrechts et al., 1997; Jonckheere et al., 1999) . Nevertheless, these peptide studies do not re¯ect the af®nities of either isoform for proline-rich stretches presented in the context of a full-length protein. Recently, Suetsugu and coworkers showed pro®lin I to exhibit tighter binding to N-WASP compared with pro®lin II (Suetsugu et al., 1998) , and studies by Witke and co-workers found that pro®lin I and II associated with different functional protein complexes from mouse brain extracts. In particular, pro®lin II was found to interact with dynamin I whereas pro®lin I did not (Witke et al., 1998) . These data suggest that differences between the isoforms in and around the poly-L-proline binding site play a critical role in selecting different binding partners, which in turn link the actin cytoskeleton to distinct functional pathways.
The structure of pro®lins from human (Metzler et al., 1993; Mahoney et al., 1997; Mahoney et al., 1999) , bovine CedergrenZeppezauer et al., 1994) , Saccharomyces cerevisiae (Eads et al., 1998) , Acanthamoeba castellanii (Vinson et al., 1993; Fedorov et al., 1994a) , Arabidopsis thaliana (Thorn et al., 1997) and birch pollen (Fedorov et al., 1997) have previously been reported. Pro®lins have a common fold consisting of a central seven-stranded b-sheet¯anked by N and C-terminal helices on one side and two short helices on the other side. X-ray structure determination of bovine pro®lin I in complex with bovine b-actin de®ned the actin binding site of pro®lin as residues from helix 3, helix 4, and b-strands 4, 5, and 6. Also, crystal structures of human pro®lin I bound to poly-Lproline peptides Mahoney et al., 1999) have con®rmed a previously described surface patch of aromatic residues (Trp3, Tyr6, Trp31, His133, Tyr139) as the poly-L-proline binding site (Bjo È rkegren et al., 1993; Schutt et al., 1993; Cedergren-Zeppezauer et al., 1994; Thorn et al., 1997) . The uncomplexed structures of bovine pro®lin I and human pro®lin I are virtually identical with the actin-and poly-Lproline-complexed forms (Cedergren-Zeppezauer et al., 1994; Mahoney et al., 1997) . Here, we pre-sent the ®rst X-ray crystal structure of this second class of mammalian pro®lins, human pro®lin II. This structure reveals an aromatic extension of the poly-L-proline binding site which may explain the increased af®nity of pro®lin II for proline-rich peptides. Comparison with pro®-lin I shows the region surrounding the poly-Lproline site to have a distinct electrostatic and hydrophobic character which may explain differential ligand speci®cities.
Results

Structure determination
The asymmetric unit of human pro®lin II consists of four molecules related by approximate 222 non-crystallographic symmetry (NCS) with the central interaction of the tetramer formed by all four C-terminal helices (Figure 1 A second NCS 2-fold axis (roughly parallel with the crystallographic a-axis) relates A to B and C to D. The A:B interface includes contacts from the N and C-terminal helices burying a total of 966 A Ê 2 of solvent-accessible surface area. In contrast, a polyethylene glycol (PEG) 400 molecule is completely buried in the C:D interface which restricts direct contacts between chains C and D to include only the N-terminal residues. This PEG 400 molecule is stably bound with an average B-factor of 18.2 A Ê 2 , and may account for the requirement of PEG 400 in the crystallization mixture.
Main-chain C a atoms of A and B superimpose with an rms deviation of 0.26 A Ê while C and D C a atoms superimpose with an rms deviation of 0.09 A Ê . C a superposition of A or B onto C or D results in a slightly higher rms deviation of 0.47 A Ê . The ®rst two amino acids are visible only in chains C and D, and the last two residues are disordered in all four chains. Also, the electron density is poor for residues 92-95 of the loop preceding b-strand 6 of chain B, whereas it is clearly de®ned for chains C and D. The presence of a second bound PEG 400 molecule and close packing contributes to differences in the local environments of this loop region in chains C and D. A sulfate molecule from the crystallization buffer is bound to each molecule in the asymmetric unit, coordinated by the sidechains of Arg88, Asn99, His119, the main-chain amide group of Gly120 and the side-chain of Arg74 of a non-crystallographically related molecule. Similarly, two structures of human pro®lin I (PDB accession code: 1®k and 1®l; referenced in Materials and Methods) have a phosphate and a sulfate group positioned in the same location and coordinated by the same side-chains.
Structural overview of human profilins
Mammals express two isoforms of pro®lin in which each isoform class, I or II, is conserved between species. Human pro®lin I and II are 62 % identical in primary sequence and share the same fold (Figure 2 (a) and (b)). Residues 3 to 136 of human pro®lin I and II superimpose with an average C a rms deviation of 1.13 A Ê (C a atoms of chains A, B, C, and D were each superimposed onto crystal structures of human pro®lin I (PDB accession code: 1®k; 1®l; 1awi)). Slight deviations in the main chain are visible around loops preceding bstrands 2 and 6.
Based on sequence alignment, all amino acid differences between human pro®lin I and II which are solvent exposed (>10 A Ê 2 of solvent-accessible surface area) are highlighted on a surface rendering of human pro®lin II in Figure 3 . These differences span most of the surface of the protein with the exception of the majority of the actin and poly-L-proline binding surfaces. A total of ®ve amino acid differences, S56E, Y59F, V60T, E82D, and L122T (the ®rst and second letters are the amino acids found at the given positions of human pro®-lin I and II, respectively) are found in the actinbinding face. Residues surrounding the poly-L-proline binding site display a wide range of sequence variation which could result in differential binding speci®cities for proline-rich ligands.
The differences in sequence between the human pro®lin isoforms result in locally unique surface chemistry and topology without disruption of the pro®lin fold. Presumably, the presence of particu- (Kwiatkowski & Bruns, 1988) ; human pro®lin II (Honore Â et al., 1993) ; bovine pro®lin I (Ampe et al., 1988) ; bovine pro®lin II (Lambrechts et al., 1995) ; mouse pro®lin I (Widada et al., 1989) ; mouse pro®lin II (medline accession: AI322548)). Amino acid differences are shaded, and pro®lin I and putative pro®lin II poly-L-proline binding residues are boxed. Sequence alignment was generated using AMPS and ALSCRIPT (Barton et al.,1990; Barton et al., 1993) . (b) Superposition of human pro®lin I and II. Residues 3 to 136 of 1®k (red) were superimposed onto chain D of pro®lin II (blue). Secondary structural elements are labelled (a, alpha-helix; b, beta-strand). lar intramolecular interactions are selectively maintained throughout evolution. For example, the second isoform of pro®lin has three cysteine residues (Cys12, Cys15, and Cys16) located on a structurally conserved loop following the N-terminal helix ( Figure 4 ). Cys16 is conserved in pro®lin I and displays the same rotomer conformation as in pro®lin II. The sulfur atom of Cys15 (pro®lin II) is positioned similarly to the g-oxygen atom of Thr15 (pro®lin I), and both form electrostatic interactions Figure 3 . (a) and (b) Amino acid residue differences of the human pro®lins. A surface rendering of human pro®lin II (chain D) with colored regions highlighting amino acid residues which differ in human pro®lin I (blue, nonconserved amino acid changes; brown, conserved amino acid changes). Sites of the more dramatic differences are labelled, e.g. S29Y, with the ®rst letter representing the amino acid in human pro®lin I followed by the residue number, ending with the amino acid present in human pro®lin II. Human pro®lin II was superimposed with human pro®lin I and bound proline peptide (PDB accession code: 1awi) to orient the poly-L-proline binding groove. Image (b) is rotated 180 about the y-axis with respect to (a). Image was generated using the program GRASP (Nicholls et al., 1991) . with the carboxylate group of Asp13. There is a conserved hydrogen-bonding network in and surrounding this loop which includes coordination of a water molecule by Asp13, the carbonyl oxygen atom of Leu10, and the backbone amides of residues 15 and 16. The side-chain of Asp13 also forms a hydrogen bond with the terminal amino group of Lys126, found on the second turn of the C-terminal helix. Additionally, Met11 extends from the ®nal turn of helix 1 to pack against the base of this loop, which positions its d-sulfur atom in proximity to the conserved loop.
Actin binding surface
In the X-ray structure of bovine pro®lin I complexed to b-actin, approximately 1050 A Ê 2 of the pro®lin I surface is excluded from solvent. Many pro®lin I residues which either directly interact with b-actin or act to position side-chains contacting actin are conserved in the pro®lin II isoform. Suetsugu et al. (1998) demonstrated dramatic loss of af®nity for actin as a result of pro®lin His119 mutation to glutamic acid. In the pro®lin:b-actin complex, this histidine residue protrudes from the surface of pro®lin and sits in a pocket largely formed by Tyr133, Tyr169, Met355, and Phe375 of actin. Similar to His119, Phe59 contributes to the stabilization of the pro®lin:actin complex. Mutation of Phe59 to alanine results in the disruption of the p-stacking interaction with His173 of actin and a 14-fold decrease in af®nity for actin (Schlu È ter et al., 1998) . In contrast to His119, the rotomer conformation of Phe59 appears to be stabilized by three conserved residues in pro®lin ( Figure 5 ). The aromatic ring of Phe59 participates in a T-shaped stacking arrangement (McGaughey et al., 1998) with Phe58 which in turn participates in an amino/aromatic interaction (Mitchell et al., 1994; Burley & Petsko, 1986) with the d-guanido group of Arg55. This arginine is partially stabilized by an electrostatic interaction with the carboxylate oxygen atoms of Asp75.
The actin-binding face of bovine pro®lin I originally de®ned by Schutt et al. (1993) was used as the basis for comparing the putative actin binding sites of the human pro®lins. Overall, the actinbinding region of human pro®lin I is very similar to that of human pro®lin II with the exception of ®ve amino acid differences. As seen in Figure 3 (b), two notable differences are hydrophobic residues Val60 and Leu122 of human pro®lin I which are threonine in human pro®lin II. In the bovine pro®-lin I:b-actin complex, the closest atom to the sidechain of Met122 of pro®lin is 5.42 A Ê away (C b of Met122 to the e-carbon atom of actin Lys373). The absence of side-chain contact and indifference to size at amino acid position 122 suggest that this residue contributes little to the stabilization of the pro®lin:actin complex. Val60 of bovine pro®lin I forms a more involved peripheral interfacial contact, packing against Val287 and Arg290 of actin. In human pro®lin II, the threonine residue at position 60 displays a similar rotomer conformation as that of bovine pro®lin I Val60. The substitution of a hydroxyl for a g-methyl group at position 60 could allow for an additional hydrogen bond to the backbone carbonyl group of position 285 or the guanidium group of Arg290 of actin. Additionally, Cedergren-Zeppezauer et al. (1994) noted that the presence of glutamic acid in position 56 of pro®lin II (serine in pro®lin I) could result in the formation of a salt bridge to Lys284 of actin. The two ®nal differences between human pro®lin I and II are conserved in character. Similar to Glu82 of bovine pro®lin I, the carboxylate group of Asp82 in pro®-lin II would be expected to form a salt bridge with the amino-terminal group of Lys113 of actin. Amino acid position 59 is phenylalanine in all known mammalian pro®lin sequences, with the exception of human pro®lin I which encodes a tyrosine residue. The additional terminal hydroxyl group would not be capable of forming an intermolecular hydrogen bond with actin, and thus would not contribute an additional energy of binding.
It has been shown in the case of human growth hormone binding to its receptor that residues which make signi®cant contributions in binding energy, known as``hot spots'', are surrounded by residues which contribute little to binding energy (Clackson & Wells, 1995) . Interestingly, all of the differences between human pro®lin I and II lie on the periphery of the actin binding surface (Figure 6 ). Residues at these positions would be expected to have little contribution to binding energy with the exception of the aromatic at position 59. Mutation of Phe59 to alanine (K d mutant 34 mM, K d wild-type 2.3 mM; Schlu È ter et al., 1998) corresponds to a binding energy of 1.53(AE0.28) kcal/mol, or more than 16 % of the total binding energy. Additionally, the amino acid identity, dramatic reduction in actin af®nity upon mutagenesis (Sohn et al., 1995; Suetsugu et al., 1998; Korenbaum et al., 1998) , and structural location in the pro®lin:actin interface of three conserved residues in mammalian pro®lins, Arg74, Arg88 and His119, suggest these residues are also key energetic contributors (Figure 6 ). In contrast, positions 56, 60, 82, and 122 may function in the exclusion of solvent from the key energetic interactions (Bogan & Thorn, 1998) due to their location in the actin-binding face, amino acid identity, and the comparable af®nities of the human pro®lin isoforms towards actin.
Poly-L-proline binding site
As determined by site-directed mutagenesis and later con®rmed by crystallographic studies, residues in pro®lin I which directly interact with stretches of poly-L-proline are Trp3, Tyr6, Trp31, His133, and Tyr139 (Bjo È rkegren et al., 1993; Mahoney et al., 1997; Mahoney et al., 1999) . Superposition of human pro®lin II onto human pro®lin I complexed to a pentadeca-prolylpeptide (1cjf) allows for an analysis of the peptide:pro®lin II interactions (Figure 7(a) ). Comparison of human pro®lin I poly-L-proline binding residues Trp3, Tyr6, Trp31, and His133 with the analogous positions in human pro®lin II reveals virtually identical rotomer conformations. In human pro®lin II, amino acid positions 133 and 139 are tyrosine and valine residues, respectively. Analogous to His133 of human pro®lin I, Tyr133 of human pro®lin II is capable of hydrogen bonding to the carbonyl oxygen atom of Pro11 and stacking against Pro13 of the pentadecapeptide (proline numbering according to 1cjf complex). Due to the disordering of the last two amino acids in human pro®lin II, backbone positioning of Val139 was modelled based on main-chain positioning of Tyr139 of human pro®-lin I, showing Val139 positioned to make van der Waals contact with Pro10.
Due to the presence of tyrosine at position 29 in human pro®lin II, a slight shift in the proline pentadecamer was introduced in the ®rst six proline residues to relieve minor clashes. The most striking feature of the pentadecamer modelled onto human pro®lin II is the evident extension of the aromatic region of the poly-L-proline binding site in human pro®lin II by Tyr29 (Figure 7(a) ). This tyrosine residue protrudes from the surface of human pro®lin II and Figure 6 . Conserved key residues and non-conserved isoform differences highlighted at the pro®lin:actin interface. The bovine pro®lin I:b-actin complex (top; 2btf) has been opened and rotated towards the observer to reveal the protein binding surfaces (light blue). Human pro®lin II (bottom) was superimposed onto bovine pro®lin I and translated. Residues colored red (Phe59, Arg74, Arg88 and His119) have been shown to contribute signi®cantly to actin binding. The footprints of these residues are shown mapped onto b-actin as red transparent outlines. The differences between human pro®lin I and II at the actin-binding surface are colored dark blue (S56E, V60T, E82D, and L122T; ®rst letter corresponds to pro®lin I, the second to pro®lin II). Although position 59 differs between human pro®lin I and II (Y59F) the essential character is conserved.
accommodates an additional turn of the poly-Lproline helix. Tyr29 has the potential to form a stacking interaction with Pro3 and a hydrogen bond with the carbonyl group of Pro4, whereas position 29 in pro®lin I is a serine residue which makes van der Waals contacts to Pro3. Another unexpected difference occurs at amino acid position 12. Cys12 of pro®lin II is capable of contributing a larger surface area to interact with Pro16 than Ala12 of pro®lin I (Figure 7(a) ).
Isoform-speci®c interactions contribute to variations in the local architecture of the loop contain- ing residue 29 (Figure 7(b) ). Two charged residues unique to the pro®lin II isoform, Lys28 and Asp48, participate in an electrostatic interaction in which the amino group of Lys28 forms a hydrogen bond with the carboxylate group of Asp48, a residue on helix 2. Pro®lin I has proline in amino acid position 28 which forms a van der Waals interaction with Pro44 of helix 2. A second stabilizing interaction in pro®lin II is formed between the carboxylate group of Asp26 which participates in an electrostatic interaction with the guanidinium group of Arg107, a residue found on the b-turn preceding b-strand 7. Although the charges at position 26 and 107 are conserved in both human pro®lin isoforms, they do not form an electrostatic interaction in any of the structures of human pro®lin I (1®k, 1®l, 1awi and 1cjf). Instead, the terminal amino group of Lys25 forms a weak salt bridge (4.2 A Ê ) to the carbonyl oxygen atom of Asp106 (not illustrated in Figure 7(b) ). In addition, the positioning of the backbone in human pro®lin II places the carbonyl oxygen atom of Ala27 within hydrogen bonding distance of the indole nitrogen atom of Trp31. Furthermore, the carbonyl oxygen atom of Ala27 hydrogen bonds with the backbone amide of Tyr29 forming an i to i 2 hydrogen bond characteristic of g-turns. Residues 27 to 29 of human pro®lin II form an inverse g-turn with a negative f value for the (i 1) position, whereas residues 25-27 of human pro®lin I form a classic g-turn with a positive phi value for the (i 1) position (MilnerWhite et al., 1988) . The positioning of this loop region in pro®lin II may be important for presentation of Tyr29 in a spatial context competent for binding to poly-L-proline.
It has been shown that hydrophobicity plays an important role in protein:protein interactions (Janin & Chothia, 1978) . A hydrophobic patch on bovine pro®lin I has been previously described which is separated by a polar strip of residues from the poly-L-proline binding site and de®ned by residues: Tyr24, Pro28, Pro44, Val51, Leu78, Phe83, Met104, Ala106, and Tyr128 (Cedergren-Zeppezauer et al., 1994) . Residues comprising this hydrophobic patch are largely conserved between bovine and human pro®lin I, with the exception of positions 104 and 106. This region in human pro®lin II is less conserved and does not form a contiguous hydrophobic patch. In contrast with the patch described for bovine pro®lin I, human pro®lin II has a surface-exposed hydrophobic region which is contiguous with the poly-L-proline binding site. This hydrophobic area, neighboring Tyr29, is made up of side-chains from Pro44, Ile45, Met49, the C d of Thr43 and the aliphatic portion of Lys28 (Figure 8) . The large aliphatic sidechains of Ile45 and Met49 protrude from the surface in human pro®lin II in contrast to the smaller side-chains of Ala45 and Val49 in human pro®lin I. These aliphatic regions near the poly-L-proline binding site may contribute to differences in ligand speci®city. Figure 8 . Charge and hydrophobic differences between human pro®lin I and II surrounding the poly-L-proline binding site. Electrostatic surface potentials of human pro®lin I (PDB accession code: 1®k) and II (chain D) were generated using GRASP (Nicholls et al., 1991) . The brown patch represents side-chains of poly-L-proline binding residues in human pro®lin I and analogous residues in human pro®lin II were colored brown and mapped to the surface. Also, the surface area of a¯anking hydrophobic region differs between the two human isoforms (only side-chains are colored green and then mapped to the surface). The proteins are displayed in the same orientation. All visible charged residues which differ between the pro®lin isoforms have been labelled.
Acidic versus basic character of the human profilins
Human pro®lin I and II are often noted for their basic and acidic isoelectric points, respectively (Honore Â et al., 1993) . Human pro®lin II has four acidic residues (Asp48, Glu56, Glu95, Asp138) and two basic residues (Lys28 and Lys68) which are not found in human pro®lin I. Likewise, human pro®lin I has four charged residues (Lys25, Lys37, Asp106, His133) which are not conserved in human pro®lin II. The majority of these non-conserved differences between the two isoforms are located in (Asp138-II, His133-I) or proximal to (Lys25-I, Lys28-II, Asp48-II, Asp106-I) the poly-Lproline peptide binding site. The location of these charge differences suggests these residues might contribute to the differential af®nities displayed by the pro®lin isoforms for poly-L-proline-rich proteins (Figure 8) .
The two basic residues found in pro®lin II, but not in pro®lin I, participate in electrostatic interactions with two of the four acidic residues unique to pro®lin II. Lys28, on the loop between b-strands 6 and 7, forms a hydrogen bond with Asp48 which resides on helix 3 (Figure 7(b) ). A second pairwise hydrogen-bonding interaction occurs between Glu95 of b-strand 6 and Lys68 of b-strand 4. The remaining two non-conserved acidic residues in pro®lin II are Glu56 and Asp138. Glu56 is fully exposed and does not participate in any intramolecular electrostatic interactions. The position of Asp138 can only be approximated in human pro®lin II due to poor electron density. A molecular surface rendering of human pro®lin II indicates that Asp138 is situated adjacent to an acidic position unique to human pro®lin I (Asp106), suggesting that the localized acidic character has shifted slightly between isoforms. Similarly, each of the basic residues speci®c to human pro®lin II (Lys28, Lys68) is spatially proximal to the position of a basic residue found only in pro®lin I (Lys25, Lys37).
Discussion
The structure determination of human pro®lin II has allowed for a comparative analysis of the two human pro®lin isoforms. Amino acid differences between the isoforms are seen throughout the surface of the protein with the exception of the majority of the actin and poly-L-proline binding faces. These differences contribute to locally unique chemical environments and topologies, which form the structural basis for functional distinctions between pro®lin I and II.
Mammalian pro®lin II isoforms display a higher af®nity for proline-rich peptides than pro®lin I (Lambrechts et al., 1997; Jonckheere et al., 1999) . Binding experiments of pro®lin I and II to a VASPbased peptide containing the (GP 5 ) 3 repeat demonstrated that bovine pro®lin II bound the VASP peptide with a dissociation constant of 0.5mM whereas pro®lin I bound with a K d value of 150 mM (Jonckheere et al., 1999) . Elution of pro®lin II from poly-L-proline Sepharose requires higher DMSO (this study; see Materials and Methods) or urea (Lambrechts et al., 1995) concentrations than pro®lin I, also indicating that pro®lin II has a tighter association with proline-rich stretches. The higher af®nity of pro®lin II for proline-rich peptides may be attributed to the aromatic extension of the poly-L-proline binding site by tyrosine 29. The presence of tyrosine at this position, in lieu of serine as found in pro®lin I, may further stabilize a bound proline stretch through hydrogen bonding and accommodating an additional turn of the poly-L-proline type II helix via stacking and van der Waals interactions.
Other pro®lin surface features proximal to thè`c ore'' poly-L-proline binding site need to be considered when the proline stretch is presented in the context of a folded domain. Suetsugu and co-workers recently demonstrated pro®lin I binds one order of magnitude (K d 60 nM) more tightly to N-WASP over pro®lin II (K d 400 nM; Suetsugu et al., 1998) . Notably, the proline-rich region of N-WASP harbors several of the (GP 5 ) repeats albeit not consecutively as in VASP. The discrepancy between the tighter binding of pro®-lin II to (GP 5 ) 3 and the higher af®nity of pro®lin I to full-length N-WASP strongly suggests that regions¯anking the poly-L-proline binding site are important for these differences in speci®city. As was shown in the case of the SH3 domains, the unusually tight binding of HIV-1 nef protein to the SH3 domain of hck is due to a region outside the aromatic poly-L-proline binding site. A region on the hck SH3 domain known as the RT loop contains isoleucine in position 96 which is critical for tight binding to HIV-1 nef protein (Lee et al., 1995) . A crystal structure complex of the conserved core of HIV-1 nef protein bound to a high af®nity mutant of fyn SH3 domain (Arg96 3 Ile) shows the critical region of binding to be located outside of the poly-L-proline binding site and increases the solvent-excluded surface area from 780 A Ê 2 (poly-L-proline peptide binding region only) to 1200 A Ê 2 (Lee et al., 1996; Lim, 1996) . Comparative structural analysis of the human pro®lin isoforms shows that six out of ten charged differences are in or proximal to the poly-L-proline binding face. Although the precise elements of structural speci®city cannot be addressed without mutagenesis and/or structural studies of the particular pro®lin:ligand complex, the differences bordering the poly-Lproline binding site may play a critical role in recognition of the region surrounding the proline-rich target.
It has been shown that a fraction of residues in a protein:protein interface contribute the majority of the binding energy (Cunningham & Wells, 1993; Clackson & Wells, 1995; Bogan & Thorn, 1998) . These key residues, referred to as hot spots, are often located near the center of the interface and are most often tryptophan, arginine, or tyrosine residues. In contrast, residues which lie on the periphery of the interface typically make insigni®cant contributions to binding energy, and are thought to function primarily in the exclusion of solvent (for a review, see Bogan & Thorn, 1998) . With respect to the pro®lin:actin interaction, both pro®-lin isoforms show comparable af®nity to actin which is consistent with the maintenance of key actin binding residues and the location and nature of the amino acid differences between isoforms (Figure 6 ). Although systematic alanine-scanning of the actin binding surface of pro®lin along with the respective dissociation constants has not been reported, mutagenesis studies of Phe59 (Schlu È ter et al., 1998), Arg74 (Korenbaum et al., 1998) , Arg88 (Sohn et al., 1995) and His119 (Suetsugu et al., 1998) show dramatic effects on actin af®nity, and suggest that these residues may be hot spots. The peripheral differences between the human pro®lin isoforms (positions 56, 60, 82, and 122) may result in kinetic differences in the association rates of pro®lin I and II with actin, as was seen in the case of human growth hormone and its receptor that peripheral electrostatic residues function to increase the rate of association (Cunningham & Wells, 1993) .
The binding of PIP 2 to either of the mammalian pro®lin isoforms disrupts the pro®lin:actin complex, however there is disagreement as to the relative af®nities of each isoform for polyphosphoinositides (Gieselmann et al., 1995; Lambrechts et al., 1997) . It has been suggested that pro®lin is capable of associating with several PIP 2 molecules via pro®lin's positive electrostatic surface potential (Goldschmidt-Clermont et al., 1990; Fedorov et al., 1994a) . There are ten charged differences between human pro®lin I and II and structural comparison shows that many of these differences are spatially close to the position of the charged residue in the other isoform (Asp138-II and Asp106-I; Lys28-II and Lys25-I; Lys68-II and Lys37-I) such that on a global scale the human pro®lin isoforms appear to share the same electrostatic patterns. Similar to Acanthamoeba pro®lin I and II (Fedorov et al., 1994a) , the electrostatic surface of each of the two human isoforms presents two large basic patches that are separated by a common border of acidic residues (data not shown). Mutagenesis of single amino acids has been carried out to locate residues critical for PIP 2 interaction (Haarer et al., 1993; Sohn et al., 1995) , yet none abolish binding. Mutation of Arg88 to leucine in human pro®lin I results in a threefold decrease in PIP 2 binding (Sohn et al., 1995) . Interestingly, in three of the human pro®lin crystal structures (1®k, 1®l, and here), a negatively charged phosphate or sulfate anion is bound to a basic pocket consisting of Arg88, Asn99, His119 and the mainchain amide of residue 120. Notably, 1®k was solved in low salt, 30 % PEG 8000 and 50 mM potassium phosphate (Fedorov et al., 1994b) , which would correspond to a 1:100 ratio of pro®lin I to phosphate. The general propensity of pro®lin to accommodate a negatively charged group in this pocket lends support to the idea that these residues participate in phophoinositide binding.
Overall, pro®lin isoforms from many different species share the same global biochemical characteristics even with a considerable degree of sequence variation. The two human isoforms have a higher level of sequence similarity, and yet differences on the atomic level re¯ect the distinct signalling and biochemical pathways speci®c to the tissues in which each isoform is expressed. The ®nding that pro®lin I and pro®lin II associate with different functional complexes from brain lysates indicates that these isoforms have distinct roles in tissues where they are coexpressed (Witke et al., 1998) . Sequence variation between pro®lin I and II also suggests the ability to bind to proline-rich ligands is differentially regulated by phosphorylation. Pro®lin I is phosphorylated on Tyr139 in an EGF-stimulated assay which leads to the inability to bind to poly-L-proline (Bjo È rkegren-Sjo È gren et al., 1997); whereas pro®lin II encodes a valine or phenylalanine residue in position 139. An atomic resolution structure of pro®lin in complex with a full-length proline-rich protein will be necessary to elucidate the structural determinants not evident in the structural studies of pro®lin:peptide complexes. The comparative analysis presented here will aid characterization of the pro®lin:ligand interface with respect to isoform speci®city, and may provide insight into the basis for two distinct pro®lin isoforms.
Materials and Methods
Expression and purification of human profilin II
The cDNA for human pro®lin II was obtained from ATCC #84635, subcloned into a pET/T7 plasmid (Novagen) and transformed into Escherichia coli strain BL21(DE3). Low protein expression due to two unpreferred arginine codons was boosted using an ArgU plasmid (courtesy of Professor J. Walker), resulting in approximately 20 mg of protein from a ten liter fermentor growth. Human pro®lin II was puri®ed according to Lindberg et al. (1988) with modi®cations. Brie¯y, the freeze-thaw technique (Johnson & Hecht, 1994 ) was used to extract human pro®lin II without cell lysis into the poly-L-proline Sepharose loading buffer A (10 mM TrisHCl (pH 8.0), 100 mM KCl, 100 mM glycine). The puri®-cation was performed in batch and human pro®lin II was eluted from the poly-L-proline Sepharose in several washes of buffer A with 50 % DMSO in contrast to 30 % for the pro®lin I isoforms. Protein was dialyzed into 15 mM Tris (pH 7.5), 50 mM KCl under nitrogen and concentrated by ultra®ltration to 30 mg/ml. Human pro®lin II was passed over an S-100 column (Pharmacia), desalted using a PD-10 column (Pharmacia) into 15 mM Tris-HCl (pH 7.5), 10 mM DTT and concentrated by ultra®ltration (Amicon/centricon) to 18 mg/ml. Protein purity was monitored by silver and Coomassie stain as well as electrospray mass spectroscopy which showed a molecular mass corresponding to human pro®lin II lacking an amino-terminal methionine residue. This recombinantly expressed pro®lin lacked the N-terminal acetylation commonly observed on pro®lins puri®ed from mammalian tissue. Protein concentration was measured using an extinction coef®cient of 1.4 at 280 nm.
Crystallization and data collection
Human pro®lin II crystals grew in hanging drops consisting of 2 ml of protein solution mixed 1:1 with and equilibrated against a well solution of 1.35 M MgSO 4 , 1.5 % (v/v) PEG 400, 100 mM Hepes (pH 7.3) at 4 C. Crystals were bathed in increasing concentrations of ethylene glycol plus mother liquor and¯ash frozen at a ®nal concentration of 12 % (v/v) ethylene glycol. Data were collected at 100 K at Brookhaven National Laboratories on beamline X9B. Human pro®lin II crystallized in the space group P2 1 with four molecules in the asymmetric unit. Data reduction and scaling were performed using DENZO/HKL suite (Otwinowski & Minor, 1997;  see Table 1 ).
Structure determination
Bovine pro®lin I (PDB accession code 1pne) was employed as a molecular replacement search model, with all non-conserved residues modi®ed to alanine. Molecular replacement solutions for all four molecules in the asymmetric unit were determined using AMoRe (Navaza, 1994) as part of the CCP4 suite of programs (Collaborative Computational Project, 1994) . The ASU is a dimer of dimers with roughly 222 NCS symmetry. Cycles of building and re®nement were performed using O (Jones et al., 1991) and XPLOR with bulk solvent correction (Bru È nger, 1993) . During the ®rst cycles of re®ne-ment NCS restraints grouped all four molecules. In later stages NCS restraints grouped A to B and C to D, and in the ®nal rounds of re®nement all NCS restraints were lifted. Solvent molecules were added to stereochemically sensible positions and a sulfate group was placed in identical positions for each of the four chains. Also, two PEG 400 molecules of varying length were modelled as described in the text.
Analysis
Structures of mammalian pro®lin I used in structural comparisons with human pro®lin II were: PDB accession code 1®k (human pro®lin I crystallized in low salt; Fedorov, A.A., Pollard, T.D., Almo, S.C.), 1®l (human pro®lin I crystallized in high salt; Fedorov, A.A., Pollard, T.D., Almo, S.C.), 1cjf (Mahoney et al., 1999) , 1awi , 1pne (Cedergren-Zeppezauer et al., 1994) , and 2btf . All solvent-accessible surface area calculations were performed using GRASP with a probe radius of 1.4 A Ê (Nicholls et al., 1991) . Protein secondary structure was analyzed using PROMOTIF (Hutchinson & Thornton, 1996) and protein superpositions were performed using O (Jones et al., 1991) .
Coordinates
The coordinates and experimental amplitudes have been deposited in the Protein Data Bank (PDB accession code 1D1J). 
